Device Week, March 14, 2019 – Smith & Nephew Buys Osiris To Boost Wound Care Business

In this edition of Device Week, Medtech Insight’s Catherine Longworth discusses Smith & Nephew’s $660m acquisition of regenerative medicine company Osiris Therapeutics and Reed Miller talks about the clinical trial highlights from the recent CRT Meeting in Washington and looks forward to the American College of Cardiology conference next week. For more information on Medtech Insight and to start a free trial, click here. https://pharmaintelligence.informa.com/products-and-services/news-and-insights/medtech-insight Medtech Insight articles addressing topics discussed in this episode: AAOS 2019: OSSO VR Develops VR Training Tool For Smith & Nephew's NAVIO Robot, And More On Orthorobotics https://bit.ly/2XOGuto 2018 Earnings Spotlight: Stryker And Nuvasive Lead The Ortho Pack In 2018 https://bit.ly/2TAB3je Exec Chat: New Smith & Nephew CEO Namal Nawana Outlines Growth Strategy At JP Morgan https://bit.ly/2GHcWIi Results Recap: CRT In DC Features New Biotronik Stent Data, Encouraging TAVR Low-Risk Data; Ablative Systems’ Alcohol Renal Denervation https://bit.ly/2W1CkfV Drug-Coating Safety Risk Acknowledged At Cardiology Gathering, But Cause Remains Elusive https://bit.ly/2TLcfEF 2018 Earnings Spotlight: Transcatheter Valve Repair Remains Big Drivers For Medtronic, Edwards, Abbott https://bit.ly/2VIoQ8V